Email this article Using of transcutaneous supraorbital nerve stimulation in the treatment of chronic tension type headache
- Authors: Yakupov E.Z.1, Agliullina F.F.2
-
Affiliations:
- Kazan State Medical University
- LLC “Hotel-clinic”
- Issue: Vol LIV, No 1 (2022)
- Pages: 23-30
- Section: Original study arcticles
- URL: https://journal-vniispk.ru/1027-4898/article/view/89577
- DOI: https://doi.org/10.17816/nb89577
- ID: 89577
Cite item
Open Access
Access granted
Subscription Access
Abstract
BACKGROUND. The clinical study was carried out as part of the scientific work “Non-drug treatment methods and optimization of coping strategies for chronic tension type headache”.
AIM. To evaluate the effectiveness of the use of transcutaneous neurostimulation of the supratrochlear and supraorbital nerves in patients with chronic tension type headache.
MATERIAL AND METHODS. The clinical study was conducted from February to August 2021. In total, 50 patients with chronic tension type headache took part in the study, which were divided into two groups: the main group (40 participants) and the control group (10 participants). In the main group, patients received transcutaneous neurostimulation of the supratrochlear and supraorbital nerves with low-frequency (60 Hz) impulses. In the control group, participants received only drug therapy. One month after the end of the course of treatment, the intensity, frequency of headache, the amount of drugs taken, and the effect of headache on work ability were assessed. Statistical processing was performed in the IBM SPSS program using tests for nonparametric data and tests of signs and Wilcoxon. The results of the data were taken as significant at p <0.05.
RESULTS. In the main group, there was a statistically significant (p <0.05) decrease in the frequency of headache episodes by 1.8 times, the number of analgesics consumed by 2.8 times, and the intensity of headache by 50%. We also observed a decrease in the effect of headache on the ability to work of patients from 79 to 47.3%. At the same time, there were patients whose headache did not affect their ability to work. In the control group we did not notice significant dynamics in the frequency of episodes and the intensity of headache.
CONCLUSION. In our opinion, non-invasive percutaneous neurostimulation of the supratrochlear and supraorbital nerves is an additional option for preventive treatment in patients with chronic tension type headache.
Full Text
##article.viewOnOriginalSite##About the authors
Eduard Z. Yakupov
Kazan State Medical University
Email: ed_yakupov@mail.ru
ORCID iD: 0000-0003-2965-1424
SPIN-code: 2077-9609
Dr. Sci. (Med.), Professor, head of the Department of neurology, neurosurgery and medical genetics
Russian Federation, 420012, Kazan, Butlerova Str., 49Faniya F. Agliullina
LLC “Hotel-clinic”
Author for correspondence.
Email: fanagli@mail.ru
ORCID iD: 0000-0001-7888-545X
SPIN-code: 6339-5268
neurologist of the rehabilitation department
Russian Federation, KazanReferences
- Rizzoli P, Mullally William J. Headache. The American Journal of Medicine. 2018;131(1):17–24. doi: 10.1016/j.am med.2017.09.005.
- Robbins Matthew S. The epidemiology of primary headache disorders. Seminars in Neurology. 2010;30(2):107–119. doi: 10.1055/s-0030-1249220.
- Kristoffersen Espen Saxhaug, Stavem K, Lundqvist C, Russell MB. The impact of chronic headache on workdays, unemployment and disutility in the general population. Journal of Epidemiology and Community Health. 2019;73(4):360–367. doi: 10.1136/jech-2018-211127.
- Nichols E, Feigin V. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A syste- matic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2018;17(11):954–976. doi: 10.1016/S1474-4422(18)30322-3.
- Hagen K, Åsberg AN, Uhlig BL et al. The epidemiology of headache disorders: a face-to-face interview of participants in HUNT4. J Headache Pain. 2018;19(1):25. doi: 10.1186/s10194-018-0854-2.
- Osipova VV, Tabeeva GR. Pervichnye golovnye boli: diagnostika, klinika, terapiya: prakticheskoe rukovodstvo. Moscow: MIA, 2014. 336 p. (In Russ.)
- Prishchepa AV, Danilov AB. Metod biologicheskoj obratnoj svyazi v lechenii hronicheskoj golovnoj boli i komorbidnyh rasstrojstv. RMJ. 2018;4(1):60–65. (In Russ.)
- Urits I, Schwartz R, Smoots D et al. Peripheral neuromodulation for the management of headache. Anesth Pain Med. 2020;10(6):1–10. doi: 10.5812/aapm.110515.
- Latysheva NV. Lechenie hronicheskoj golovnoj boli: vsegda li my mozhem sledovat’ mezhdunarodnym rekomendaciyam? Medicinskij alfavit. Seriya “Nevrologiya i psihiatriya”. 2019;3(24):5–9. (In Russ.) doi: 10.33667/2078–5631–2019–3–24(399)-5–9.
- Schoenen J, Vandersmissen B, Jeangette S et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697–704. doi: 10.1212/WNL.0b013e3182825055.
- Przeklasa-Muszyńska A, Skrzypiec K, Kocot-Kępska M et al. Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly® device in prevention of primary headaches. Neurol Neurochir Pol. 2017;51(2):127–134. doi: 10.1016/j.pjnns.2017.01.004.
Supplementary files
